What You Should Know:
- CLEW is awarded FDA Emergency Use Authorization (EUA)
for its predictive analytics platform in support of COVID-19 patients.
- CLEW is the only device authorized by the FDA to
provide early identification of patients who are likely to experience
respiratory failure of hemodynamic instability—both significant complications
associated with COVID-19.
- CLEW is already implemented in coronavirus units in two
Israeli hospitals, and being tested by several US
Read More
Coronavirus (COVID-19)
Redox, Curative Partner to Connect COVID-19 Test Results to Public Health Depts.
What You Should Know:
- Curative and Redox have found a way to easily send COVID-19 test results to state officials for reporting, contact tracing programs, and to inform policies as regions move through phases for re-opening the economy.
- Since formalizing the partnership in May, the duo has kicked off projects with 24 states, with two, Illinois and Delaware, now fully live.
- In this novel use case, Curative uses the Redox API to allow for a secure, efficient flow of data between
Read More
FDA Approves Cue Health’s Point-of-Care COVID-19 Test Using Nasal Swabs
What You Should Know:
- The Food and Drug Administration (FDA) has awarded Cue Health Emergency Use Authorization (EUA) for its rapid, portable, molecular point of care COVID-19 test.
- The company recently raised $100M in Series C funding from Menlo Park-based Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation – JJDC, Inc., ACME Capital, and other investment firms.
Cue Health Inc.
(“Cue”), a healthcare
technology company,
Read More
COVID-19: What it Means to American Healthcare: Trends, Impacts, Predictions, and the Road Ahead
What You Should Know:
- Innovaccer releases new report, “COVID-19: What it
Means to American Healthcare: Trends, Impacts, Predictions, and the Road Ahead”
that uncovers a two-fold strategy for healthcare organizations to predict the
utilization trend of resources and maps the route from immediate COVID-19
challenges to steps needed to address these barriers.
- The report probes how virtual care and telemedicine IT
solutions rose as the ray of hope in the wake of an unprecedented outbreak
Read More
Backed by Northwell, Conversa Health Raises $12M for AI-Powered Chatbots
What You Should Know:
- Conversa Health raises $12 million in Series B funding
round to expand its AI-powered chatbots enabling health systems, payers and pharmaceutical
companies to engage patients and collect patient-generated health data and
patient-reported outcomes.
- Conversa plans to use the funding to scale its virtual
care and communication platform—97 percent of patients who have used its chatbots
say they can better manage their care with Conversa.
- Murray Brozinsky
Read More
Arcadia Launches New COVID-19 Recovery Toolkit for Health Systems
What You Should Know:
- Arcadia launches COVID-19 Surveillance and
Engagement Toolkit with data and resources to help health systems in
value-based payment arrangements meet the demands of the pandemic.
- Since the introduction of Arcadia’s COVID-19 Surveillance
and Engagement Toolkit, more than a dozen health systems have used Arcadia Analytics
to reach patients via text message outreach and symptom screening tools, an
increase
Read More
The New Normal: Rethinking Healthcare Delivery in a Post-COVID World
It’s becoming clearer that, while we are all hoping that things are going to go back to the way things were at the beginning of the year, the COVID-19 crisis will result in a new normal. That’s especially true in healthcare, due to four issues that are being wildly amplified by the COVID-19 crisis. Namely:
1. The US government has huge deficits, and healthcare is a major driver of the unsustainable increase in these deficits.
2. Addressing the demand for healthcare as a right (not a
Read More
FCC Surpasses $100M in Approved COVID-19 Telehealth Program Applications
What You Should Know:
- FCC’s COVID-19 Telehealth Program, which was authorized by the CARES Act, has approved funding for 305 healthcare providers in 42 states plus Washington, D.C. for a total of $105M in funding.
The Federal Communications
Commission’s Wireline Competition Bureau today approved an additional 67 funding applications
for the COVID-19 Telehealth Program. Healthcare
providers in both urban and rural areas of the country will use this $16.87M in
funding to
Read More
Cue Health Lands $100M to Scale Rapid, Portable, Point-of-Care COVID-19 Test
What You Should Know:
- Cue Health raises $100M to commercialize its portable, molecular diagnostic test capable of detecting SARS-CoV-2, the virus that causes COVID-19, in less than 25 minutes using a simple nasal swab.
- The test is part of the Cue Health Monitoring System, which is designed to be a portable device that can perform a molecular test and connect patients to a mobile health platform that features interventional components such as telemedicine
Read More
ChristianaCare Deploys Employee COVID-19 Symptom Monitoring and Testing Program
What You Should Know:
- ChristianaCare develops telehealth Employee COVID-19 Symptom Monitoring and Testing Program that allows employers to take proactive, responsible step to ensure workforce safety as they open for work.
- The program relies on ChristianaCare’s COVID-19 Virtual Practice and its award-winning CareVio care management program for daily bi-directional, secure text messaging.
- Currently, 12 employers in Delaware, Pennsylvania, New Jersey, Louisiana, and Arizona are
Read More
